1996
Temporal Trends of Initial CD4 Cell Counts Following Human Immunodeficiency Virus Seroconversion in Italy, 1985–1992
Galai N, Lepri A, Vlahov D, Pezzotti P, Sinicco A, Rezza G, Study H. Temporal Trends of Initial CD4 Cell Counts Following Human Immunodeficiency Virus Seroconversion in Italy, 1985–1992. American Journal Of Epidemiology 1996, 143: 278-282. PMID: 8561162, DOI: 10.1093/oxfordjournals.aje.a008739.Peer-Reviewed Original ResearchConceptsCD4 cell measurementsInitial CD4 cell countHuman immunodeficiency virus (HIV) seroconversionCD4 cell countCell countCD4 cell count increaseItalian Seroconversion StudyLow CD4 countMonths of seroconversionYear of seroconversionCD4 cell levelsCell count increaseMedian lag timeCD4 countCD4 levelsHIV seroconversionPositive serologyNegative serologyHIV seroconvertersClinical centersRisk groupsSeroconversion StudySeroconversionMultivariate modelLag time
1995
Factors Associated with Initiation of Zidovudine in a Cohort of Injection Drug Users
Solomon L, Vlahov D, Astemborski J, Galai N, Graham N, Nelson K. Factors Associated with Initiation of Zidovudine in a Cohort of Injection Drug Users. Journal Of Drug Issues 1995, 25: 225-233. DOI: 10.1177/002204269502500115.Peer-Reviewed Original Research
1993
Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection
Herskowitz A, Vlahov D, Willoughby S, Chaisson R, Schulman S, Neumann D, Baughman K. Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. The American Journal Of Cardiology 1993, 71: 955-958. PMID: 8465788, DOI: 10.1016/0002-9149(93)90913-w.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusCongestive heart failureLeft ventricular dysfunctionLV dysfunctionHeart failureVentricular dysfunctionConsecutive human immunodeficiency virusSymptomatic congestive heart failureHuman immunodeficiency virus (HIV) infectionCardiac contractile abnormalitiesHIV clinic populationLow CD4 countImmunodeficiency virus infectionClinical heart diseaseCD4 countHIV clinicHIV infectionContractile abnormalitiesImmunodeficiency virusRecent onsetClinic populationHeart diseaseCrude rateVirus infectionPatients
1992
Immune Serum Markers and CD4 Cell Counts in HIV-Infected Intravenous Drug Users.
Chaisson R, Taylor E, Margolick J, Muñoz A, Solomon L, Cohn S, Nelson K, Vlahov D. Immune Serum Markers and CD4 Cell Counts in HIV-Infected Intravenous Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1992, 5: 456. PMID: 1348535, DOI: 10.1097/00126334-199205000-00004.Peer-Reviewed Original ResearchConceptsCD4 cell countSerum immune markersDrug use patternsCell countCD4 countHIV statusImmune markersImmune activationDrug usersHuman immunodeficiency virus (HIV) infectionHIV-seropositive individualsImmunodeficiency virus infectionSerum IgA levelsIntravenous drug usersAssociation of raceIgA levelsNeopterin levelsSerum markersVirus infectionLarge cohortBacterial infectionsHIVHepatitisInfectionMarkers
1991
Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus.
Solomon L, Frank R, Vlahov D, Astemborski J. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. American Journal Of Public Health 1991, 81: 1285-90. PMID: 1928527, PMCID: PMC1405342, DOI: 10.2105/ajph.81.10.1285.Peer-Reviewed Original ResearchConceptsIntravenous drug usersCD4 cell countDrug usersHealth servicesHIV serostatusClinical symptomsHIV-seropositive intravenous drug usersHealth insuranceCell countAsymptomatic HIV-1 infectionSeropositive intravenous drug usersHuman immunodeficiency virus (HIV) infectionHIV-seropositive drug usersOngoing natural history studyLow CD4 countHIV-1 seropositiveImmunodeficiency virus infectionHIV-1 serostatusHealth care utilizationHIV-1 infectionHIV-positive serostatusNatural history studiesHealth care servicesCD4 countMore HIV